Correspondence on 'Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation’ by Braaten et al-Reference-Cited by-同舟云学术

Correspondence on 'Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation’ by Braaten et al

Published:2020-01-06 Issue:1 Volume:81 Page:e13-e13
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Ceccarelli Fulvia^ORCID,Botticelli Andrea,Gelibter Alain Jonathan,Leccese Ilaria,Lucchetti Ramona,Cortesi Enrico,Valesini Guido,Marchetti Paolo,Conti Fabrizio

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference5 articles.

1. Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation

2. Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

3. Guidelines for musculoskeletal ultrasound in rheumatology

4. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

5. Jamal S , Hudson M , Fifi-Mah A , et al . Immune-related adverse events associated with cancer immunotherapy: a review for the practicing rheumatologist. J Rheumatol 2019:jrheum.190084. doi:10.3899/jrheum.190084

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case report of immune checkpoint inhibitor‐related myositis and cholangitis induced by pembrolizumab;Clinical Case Reports;2024-07

2. Rheumatic Diseases Development in Patients Treated by Anti-PD1 Immune Checkpoint Inhibitors: A Single-Centre Descriptive Study;Life;2023-03-25

3. Monitoring and Management of the Patient with Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis: Current Perspectives;Journal of Inflammation Research;2022-05

4. Immune checkpoint inhibitors and pre-existing antinuclear antibodies: the rheumatologist point of view;Clinical and Translational Oncology;2021-03-17

5. Immune checkpoint inhibitors-induced autoimmunity: The impact of gender;Autoimmunity Reviews;2020-08